Prospective, open, single-arm, post-marketing clinical trial on the safety and efficacy of Fufang Maqitong Capsule in the treatment of stable coronary heart disease with angina pectoris and cardiac blood stasis syndrome (including patients with mild to moderate hypertension)
100 Clinical Results associated with Hainan Yangshengtang Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Hainan Yangshengtang Pharmaceutical Co. Ltd.
100 Deals associated with Hainan Yangshengtang Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Hainan Yangshengtang Pharmaceutical Co. Ltd.